The diagnostic and therapeutic bronchoscopes will be featured at the annual American Thoracic Society meeting
CENTER VALLEY, Pa., May 13, 2024 /PRNewswire/ -- Olympus, a global medical technology company, announced today the launch of two bronchoscopes as part of the EVIS X1 Endoscopy System. The EVIS X1 Endoscopy System represents the latest in diagnostic and therapeutic bronchoscopy from Olympus.
Designed with high-definition imaging, the two bronchoscopes offer physicians a slim outer diameter when compared to predecessors, allowing access to more distal airways. Improved suction and flexibility during procedures, combined with the ability to pass a wide array of diagnostic and therapeutic devices through large working channels, provides physicians with options to successfully address the tracheal bronchial tree.1-3
Olympus will highlight the bronchoscopes during the American Thoracic Society (ATS) annual meeting May 17-22 in San Diego.
Both the diagnostic and therapeutic versions of the bronchoscopes feature a compact outer diameter and large working channel, as well as redesigned imaging and handling.
The EVIS X1 endoscopy system is Olympus' most advanced endoscopy system, offering a series of imaging technologies, including the CV-1500 video system center, which combines the video processor and an LED light source in one box. The imaging technologies, available with both bronchoscopes, include:
TXI, RDI, BAI-MAC and NBI technologies are not intended to replace histopathological sampling as a means of diagnosis. These are adjunctive tools for endoscopic examination that can be used to supplement Olympus white light imaging.
"With the EVIS X1 endoscopy system, Olympus remains committed to offering physicians the best tools possible along the entire patient care pathway," said Swarna Alcorn, Business Unit Vice President, Respiratory, Olympus Corp. of the Americas. "We are excited to launch diagnostic and therapeutic bronchoscopes supported by our most advanced endoscopy system. Pulmonologists will have the confidence to expand their reach with bronchoscopes that combine a slim outer diameter, a large working channel and improved imaging."
For more information about the BF-H1100 and BF-1TH1100 bronchoscopes, visit the Olympus booth, #2543, during ATS and visit the pulmonology product page for more information about the entire Olympus pulmonology portfolio.
About Olympus
At Olympus, we are committed to our purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states.
For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world.
Olympus Corporation of the Americas, a wholly owned subsidiary of Olympus Corporation, is headquartered in Center Valley, Pennsylvania, USA, and employs more than 4,500 employees throughout locations in North and South America. For more information, visit olympusamerica.com.
1 Data on file with Olympus (DC00507026)
2 Data on file with Olympus (DC00487063)
3 Data on file with Olympus (DC00548944)
4 Data on file with Olympus (DC00507026 and DC00487063)
5 Data on file with Olympus (DC00688716)
6 Data on file with Olympus (DC0050706 and DC00487063)
7 Data on file with Olympus (DC00436067)
8 Data on file with Olympus (DC00489983)
SOURCE Olympus Corporation of the Americas